Current Report Filing (8-k)
May 14 2019 - 11:58AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of earliest event reported): May 14, 2019
TARGET
GROUP INC.
(Exact name of registrant as specified in
its charter)
Delaware
|
000-55066
|
46-3621499
|
State or other jurisdiction incorporation
|
Commission File Number
|
IRS Employer
|
|
|
Identification No.
|
55 Administration Road, Unit 13, Vaughan, Ontario, Canada
|
L4K 4G9
|
(Address of principal executive offices)
|
(Zip Code)
|
Registrant's telephone number, including area code: (647) 927-4644
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is
an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of
the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging Growth Company
x
For an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
Emerging Growth Company
¨
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Section 7- Regulation FD
|
Item 7.01
|
Regulation FD Disclosure
|
On May 14, 2019, the
Company issued a news release announcing the submission by Canary Rx Inc., the Company’s wholly-owned subsidiary, of a site
evidence package to Health Canada pursuant to its cannabis license application.
A copy of the news
release is attached as an exhibit to this Report and is incorporated herein by this reference.
Section 9- Financial Statements and
Exhibits
|
Item 9.01
|
Financial Statements and Exhibits
|
Signature
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
TARGET GROUP INC.
|
|
|
Dated: May 14, 2019
|
By:
|
/s/
Rubin Schindermann
|
|
|
Chief Executive Officer
|
Target (PK) (USOTC:CBDY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Target (PK) (USOTC:CBDY)
Historical Stock Chart
From Sep 2023 to Sep 2024